Literature DB >> 19218651

Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.

K Gorska1, R Krenke, J Domagala-Kulawik, P Korczynski, P Nejman-Gryz, J Kosciuch, K Hildebrand, R Chazan.   

Abstract

Although the clinical pictures of asthma and chronic obstructive pulmonary disease (COPD) may be similar, the pathogenesis differs in many aspects. The aim of the present study was to compare the cellular and biochemical features of airway inflammation in patients with asthma and COPD. The study was conducted in 22 patients with asthma (M/F 12/10, mean age 36 +/-14 years) and 17 patients with COPD (M/F 10/7, mean age 57 +/-11 years). Each patient underwent sputum induction followed by bronchoscopy, and bronchoalveolar lavage. Total and differential cell counts and the concentration of interleukin-8 (IL-8) and myeloperoxidase (MPO) were measured in induced sputum (IS) and BALF. We found no significant differences in the total and differential cell counts in IS between asthma and COPD patients. However, COPD patients showed an increased total macrophage count in BALF compared with asthma patients. The relative eosinophil count in BALF was significantly higher in patients with asthma vs. COPD. The concentration of IL-8 in IS and BALF was significantly higher in patients with COPD vs. asthma patients. The BALF concentration of MPO was significantly higher in patients with COPD compared with asthma patients. We conclude that the comparison of cellular composition and the concentration of inflammatory mediators in IS does not differentiate between asthma and COPD. The evaluation of BALF reveals more differences in the cellular and biochemical features of airways inflammation in patients with asthma and COPD than that of IS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218651

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  6 in total

1.  Anti-inflammatory effects of Boletus edulis polysaccharide on asthma pathology.

Authors:  Songquan Wu; Guangli Wang; Ruhui Yang; Yubao Cui
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 2.  T lymphocyte apoptosis in asthma.

Authors:  O Potapinska; U Demkow
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

3.  Relationship between airway inflammation and remodeling in patients with asthma and chronic obstructive pulmonary disease.

Authors:  K Górska; R Krenke; J Kosciuch; P Korczynski; M Zukowska; J Domagala-Kulawik; M Maskey-Warzechowska; R Chazan
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

4.  Poly-Ingredient Formulation Bresol(®) Ameliorates Experimental Chronic Obstructive Pulmonary Disease (COPD) in Rats.

Authors:  Mohamed Rafiq; Gollapalle Lakshminarayanashastry Viswanatha; Dattatray Anturlikar Suryakanth; Mohammed Azeemuddin; Mahalingaiah Jagadeesh; Krishna Dhanush; Pralhad Sadashiv Patki
Journal:  Sci Pharm       Date:  2013-05-09

5.  Sputum myeloperoxidase in chronic obstructive pulmonary disease.

Authors:  Alling Zhu; Dehai Ge; Jingying Zhang; Yue Teng; Cheng Yuan; Mao Huang; Ian M Adcock; Peter J Barnes; Xin Yao
Journal:  Eur J Med Res       Date:  2014-03-03       Impact factor: 2.175

6.  Tulobuterol patch alleviates allergic asthmic inflammation by blockade of Syk and NF-κB activation in mice.

Authors:  Lixia Fu; Jing Guan; Yujia Zhang; Pei Ma; Yuanyuan Zhuang; Jinye Bai; Yasi Ding; Qi Hou; Wan Gong; Mingbao Lin; Wensheng Zheng; Jianmin Zhang
Journal:  Oncotarget       Date:  2018-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.